✦ LIBER ✦

Interleukin-6 predicts recurrence and survival among head and neck cancer patients

✍ Scribed by Sonia A. Duffy; Jeremy M.G. Taylor; Jeffrey E. Terrell; Mozaffarul Islam; Yun Li; Karen E. Fowler; Gregory T. Wolf; Theodoros N. Teknos

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 198 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23615

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of survival in patients with

Prediction of survival in patients with head and neck cancer

✍ Robert Jan Baatenburg de Jong; Jo Hermans; Jan Molenaar; Jeroen Johannes Briaire 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

## Background: In patients with head and neck squamous cell carcinoma (hnscc) the estimated prognosis is usually based on the tnm classification. the relative weight of the three contributing parameters is often not completely clear. moreover, the impact of other important clinical variables such a

Circulating interleukin-6 predicts survi

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra

Survival of patients with palliative hea

Survival of patients with palliative head and neck cancer

✍ Quirine C. P. Ledeboer; Marc P. van der Schroeff; Jean F. A. Pruyn; Maarten F. d 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 2 views

## Abstract ## Background The purpose of this study was to describe patient characteristics and prognostic factors for survival in the palliative stage of patients with head and neck cancer. ## Methods Since November 2003, all patients with palliative head and neck cancer treated in our hospital

Prediction of recurrence by microsatelli

Prediction of recurrence by microsatellite analysis in head and neck cancer

✍ Iacopo Sardi; Alessandro Franchi; Gennaro Ferriero; Aimo Frittelli; Luca Bruschi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

Prediction of survival in patients with

Prediction of survival in patients with head and neck cancer using the histoculture drug response assay

✍ Bhuvanesh Singh; Rongou Li; Li Xu; Ashok Poluri; Snehal Patel; Ashok R. Shaha; D 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Background Chemoresponse is a significant outcome predictor in patients with head and neck cancer, regardless of the treatment modality used. The histoculture drug response assay (HDRA) has been shown to be a reliable method for in vitro chemoresponse assessment. In this study, we h

Skin melanoma of the head and neck: Prog

Skin melanoma of the head and neck: Prognostic factors and recurrence-free survival in 512 patients

✍ Anders P. Andersson; Jorgen Gottlieb; Krzysztof T. Drzewiecki; Klaus Hou-Jensen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 1 views

## Abstract The clinicopathologic and therapeutic data of 512 patients, with clinical Stage I invasive head and neck melanoma of the skin were retrospectively evaluated. There were 287 females and 225 males. Median age at primary‐surgery was 65 years (range, 18 to 96 years). Median observation peri